Rezolute
Specializing in the development of drug therapies for patients with metabolic and orphan diseases.
Launch date
Employees
Market cap
AUD449m
Enterprise valuation
AUD329m (Public information from Sep 2024)
Share price
$4.82 RZLT
Louisville Kentucky (HQ)
Authorizing premium user...